CN103570831B - 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 - Google Patents
牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 Download PDFInfo
- Publication number
- CN103570831B CN103570831B CN201310337959.XA CN201310337959A CN103570831B CN 103570831 B CN103570831 B CN 103570831B CN 201310337959 A CN201310337959 A CN 201310337959A CN 103570831 B CN103570831 B CN 103570831B
- Authority
- CN
- China
- Prior art keywords
- chain antibody
- staphylococcus aureus
- chain
- variable region
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000941 anti-staphylcoccal effect Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 35
- 239000013604 expression vector Substances 0.000 claims description 10
- 230000009465 prokaryotic expression Effects 0.000 claims description 8
- 108091008146 restriction endonucleases Proteins 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 20
- 230000007059 acute toxicity Effects 0.000 abstract description 5
- 231100000403 acute toxicity Toxicity 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 description 19
- 239000007788 liquid Substances 0.000 description 13
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 229940051173 recombinant immunotoxin Drugs 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310337959.XA CN103570831B (zh) | 2012-10-24 | 2013-08-05 | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210410235 CN102863528A (zh) | 2012-10-24 | 2012-10-24 | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 |
CN2012104102359 | 2012-10-24 | ||
CN201210410235.9 | 2012-10-24 | ||
CN201310337959.XA CN103570831B (zh) | 2012-10-24 | 2013-08-05 | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103570831A CN103570831A (zh) | 2014-02-12 |
CN103570831B true CN103570831B (zh) | 2016-06-15 |
Family
ID=47442681
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210410235 Pending CN102863528A (zh) | 2012-10-24 | 2012-10-24 | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 |
CN201310337959.XA Active CN103570831B (zh) | 2012-10-24 | 2013-08-05 | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210410235 Pending CN102863528A (zh) | 2012-10-24 | 2012-10-24 | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN102863528A (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104926941B (zh) * | 2015-06-26 | 2018-10-19 | 上海交通大学 | 牛源性抗金黄色葡萄球菌基因工程单链抗体、制备方法及其用途 |
CN104961826B (zh) * | 2015-07-14 | 2017-12-05 | 大连理工大学 | 一种金黄色葡萄球菌特异性鸡卵黄免疫球蛋白可变区单链抗体及用途 |
CN106008710B (zh) * | 2016-07-20 | 2019-11-08 | 上海交通大学 | 一种猪源性抗产肠毒素大肠杆菌K88 FaeG蛋白的单链抗体及其制备方法 |
CN106397585A (zh) * | 2016-07-29 | 2017-02-15 | 上海交通大学 | 一种牛源抗金黄色葡萄球菌的真核表达单链抗体、制备方法及其用途 |
CN106243219B (zh) * | 2016-08-04 | 2019-12-03 | 上海交通大学 | 一种猪源性抗猪流行性腹泻病毒的单链抗体及其制备方法 |
CN111333724B (zh) * | 2018-12-19 | 2022-03-15 | 中国人民解放军军事科学院军事医学研究院 | 一种抗金黄色葡萄球菌肠毒素b的单克隆抗体yg11-1及其应用 |
CN111848790B (zh) * | 2020-08-07 | 2022-02-22 | 上海交通大学 | 一种牛源抗金黄色葡萄球菌的单链抗体及其制备和应用 |
CN114409778B (zh) * | 2021-12-31 | 2023-04-11 | 上海交通大学 | 一种牛源抑制金黄色葡萄球菌溶血功能的单链抗体及其制备方法和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101892525A (zh) * | 2010-07-16 | 2010-11-24 | 复旦大学 | 天然人源IgG Fab噬菌体抗体库的构建方法 |
-
2012
- 2012-10-24 CN CN 201210410235 patent/CN102863528A/zh active Pending
-
2013
- 2013-08-05 CN CN201310337959.XA patent/CN103570831B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101892525A (zh) * | 2010-07-16 | 2010-11-24 | 复旦大学 | 天然人源IgG Fab噬菌体抗体库的构建方法 |
Non-Patent Citations (1)
Title |
---|
杨天骄,等.牛源金黄色葡萄球菌间接ELISA检测方法的建立.《中国奶牛》.2009,(第4期),32-34. * |
Also Published As
Publication number | Publication date |
---|---|
CN102863528A (zh) | 2013-01-09 |
CN103570831A (zh) | 2014-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103570831B (zh) | 牛源性抗金黄色葡萄球菌单链抗体及其制备方法和应用 | |
CN106243219B (zh) | 一种猪源性抗猪流行性腹泻病毒的单链抗体及其制备方法 | |
CN104926941B (zh) | 牛源性抗金黄色葡萄球菌基因工程单链抗体、制备方法及其用途 | |
CN110003335B (zh) | Cd47单域抗体、核酸及试剂盒 | |
CN111848790B (zh) | 一种牛源抗金黄色葡萄球菌的单链抗体及其制备和应用 | |
CN113493510A (zh) | 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用 | |
WO2024046404A1 (zh) | 一种重组肉毒杆菌毒素及其制备方法 | |
CN107304419A (zh) | 一种抗猪瘟病毒VHH抗体的酵母cDNA文库及其构建方法和用途 | |
CN109971726B (zh) | 杂交瘤细胞株及其产生的抗体和制备方法 | |
CN109306008B (zh) | 一种猪源性抗猪瘟病毒的单链抗体及其制备方法 | |
CN106008710B (zh) | 一种猪源性抗产肠毒素大肠杆菌K88 FaeG蛋白的单链抗体及其制备方法 | |
CN102746397A (zh) | 一种鸡源性抗鸡新城疫病毒p蛋白的单链抗体zl2、其制备方法及其用途 | |
Zhao et al. | Novel mycoplasma nucleomodulin MbovP475 decreased cell viability by regulating expression of CRYAB and MCF2L2 | |
CN106632670B (zh) | 一种猪源性抗猪传染性胃肠炎病毒的单链抗体及其制备方法 | |
Huo et al. | Combining the advantages of prokaryotic expression and T7 phage display systems to obtain antigens for antibody preparation | |
CN103603057A (zh) | 基于可感染病毒颗粒型抗体重链库/轻链库的抗体筛选和制备方法 | |
CN107686518B (zh) | 一种抗大肠杆菌k88ac的单链抗体及其编码基因与应用 | |
CN102731649B (zh) | 一种鸡源性抗鸡新城疫病毒的单链抗体、及其制备方法和用途 | |
CN108484770B (zh) | 重组大鼠抗小鼠cd4单克隆抗体,制备方法和应用 | |
CN107840884B (zh) | 一种抗禽类传染性支气管炎病毒的纳米抗体及其制备方法 | |
CN112342198A (zh) | PAT/pat单抗杂交瘤细胞株、产生的抗体及其制备方法 | |
CN111040023A (zh) | 一种肠炎沙门氏菌Peg菌毛受体蛋白及其RNA干扰序列与应用 | |
CN104513298B (zh) | 一种表达鸡传染性法氏囊可溶性vp 2-4-3多肽的方法 | |
CN108264541A (zh) | 一种高效表达犬圆环病毒Cap蛋白的方法 | |
CN117304311A (zh) | 一种靶向尼帕病毒g蛋白的纳米抗体、多聚化纳米抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220321 Address after: 750004 East Zone, floor 1, building 1, Ningxia high tech entrepreneurship service center, Ning'an West Lane, Xilu Road, high tech Development Zone, Jinfeng District, Yinchuan City, Ningxia Hui Autonomous Region Patentee after: Antibenda (Ningxia) Biotechnology Co.,Ltd. Address before: 200240 No. 800, Dongchuan Road, Shanghai, Minhang District Patentee before: SHANGHAI JIAO TONG University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240109 Address after: Building A8, East Zone, Jinrong Science and Technology Park, No. 158 Ji'an South Road, High tech Industrial Development Zone, Yangzhou City, Jiangsu Province, 225100 Patentee after: Antibokang (Yangzhou) Biotechnology Co.,Ltd. Patentee after: Shanghai Ancunzhi Biotechnology Co.,Ltd. Address before: 750004 East Area, 1st Floor, Building 1, Ningxia High tech Entrepreneurship Service Center, Ning'an West Lane, Xiliu Road, Jinfeng District, Yinchuan City, Ningxia Hui Autonomous Region Patentee before: Antibenda (Ningxia) Biotechnology Co.,Ltd. |